Background: Oligometastatic non-small cell lung cancer (NSCLC) represents a biologically and clinically distinct state characterized by limited metastatic spread. Increasing evidence suggests that aggressive local therapies, including surgical resection, may confer a survival benefit in this population. The objective of this review is to evaluate the current role of surgery in the management of oligometastatic NSCLC, with emphasis on patient selection, surgical strategy, integration with systemic therapy, and ongoing clinical investigations. Methods: This narrative review synthesizes retrospective and prospective clinical data, meta-analyses, major consensus guidelines, and ongoing trials since 2012. We highlight prognostic factors, staging strategies, and the evolving role of molecular and biomarker-based stratification. Results: Multiple retrospective studies and several randomized trials have demonstrated improved progression-free and overall survival with local consolidative therapy in oligometastatic NSCLC. Prognostic factors associated with favorable outcomes include a limited number of metastases (≤3), good performance status, absence of mediastinal nodal disease, metachronous presentation, and actionable molecular alterations. The integration of surgery with systemic therapies, including targeted agents and immunotherapy, has become increasingly common in selected patients. Ongoing trials such as LONESTAR, NORTHSTAR, and BRIGHTSTAR are expected to further define the role of surgery in this setting. Conclusions: Surgery is emerging as a key component of multimodal treatment for carefully selected patients with oligometastatic NSCLC. Future efforts should focus on refining patient selection through molecular stratification and expanding prospective trial data to guide personalized biology-driven treatment strategies.
Ergonomic challenges resulting in work-related injuries are highly prevalent, and women surgeons encounter more ergonomic difficulties and resultant injuries than men. Cardiothoracic (CT) surgery requires intense physical demands, and it is unknown how surgeon's sex may impact these challenges. Therefore, we sought to explore the impact of sex on ergonomic-related issues faced by CT surgeons. An anonymous web-based survey was designed and administered via a web-based platform from April 9, 2024, to April 25, 2024. Survey items addressed demographic and anthropometric data, ergonomic difficulties, pain symptoms, and associated treatments related to ergonomics in the operating room. Comparative analytics were performed between the sexes. Fifty-one participants completed the survey, including 29 practicing CT surgeons (56.9%) and 22 trainees (43.1%). The respondents included 21 women (41.2%). There was no difference in mean age by sex (40.5 years vs 40.7 years; P = .94). Women were shorter (65.3 inches vs 70.6 inches; P < .01) and had smaller hands (glove size, 6.2 vs 7.4; P < .01). Eighteen women (85.7%) reported pain compared to 20 men (66.7%; P = .23) Women more often reported an impact on daily life (83.3% [n = 15] vs 50.0% [n = 10]; P = .06). Women frequently reported needing treatment (61.1%) and time off work due to injury (27.7%). Notably, 76.2% of women (n = 16) attributed their discomfort to instruments and/or operating room setup, compared to 36.7% of men (n = 11; P = .01). The impact of work-related pain on CT surgeons is substantial, with evidence of sex differences in rates and severity. Emphasis must be placed on limiting injuries for all while specifically supporting the anthropometric diversity of our future workforce.
28 November 2024 in The Annals of Thoracic Surgery